Industry News in the Spotlight

Industry News in the Spotlight

Industry News in the Spotlight

Industry

Apr 16, 2026

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

April 16, 2026: ‘s-Hertogenbosch, the Netherlands PamDx, an innovative CRO in biomarker research and in-vitro diagnostic services, today announced the successful closing of a €13 million Series A financing round. The investment was led by Myosotis Investments, with significant participation from the European Innovation Council (EIC) Fund and the company’s existing shareholders.

Industry

Apr 16, 2026

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

April 16, 2026: ‘s-Hertogenbosch, the Netherlands PamDx, an innovative CRO in biomarker research and in-vitro diagnostic services, today announced the successful closing of a €13 million Series A financing round. The investment was led by Myosotis Investments, with significant participation from the European Innovation Council (EIC) Fund and the company’s existing shareholders.

Industry

Apr 16, 2026

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

April 16, 2026: ‘s-Hertogenbosch, the Netherlands PamDx, an innovative CRO in biomarker research and in-vitro diagnostic services, today announced the successful closing of a €13 million Series A financing round. The investment was led by Myosotis Investments, with significant participation from the European Innovation Council (EIC) Fund and the company’s existing shareholders.

Industry

From Amsterdam and Brussels to China: an overview of what is happening in the pharmaceutical industry

Industry

From Amsterdam and Brussels to China: an overview of what is happening in the pharmaceutical industry

Industry

From Amsterdam and Brussels to China: an overview of what is happening in the pharmaceutical industry

Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Industry

Success, failure, and the road to 3.9 billion: Edwin Moses on building biotech giants

Industry

Success, failure, and the road to 3.9 billion: Edwin Moses on building biotech giants

Industry

Success, failure, and the road to 3.9 billion: Edwin Moses on building biotech giants

Industry

Argenx: ‘Innovation is at the core of our business’

Industry

Argenx: ‘Innovation is at the core of our business’

Industry

Argenx: ‘Innovation is at the core of our business’

Industry

Samenwerken is ons DNA

Industry

Samenwerken is ons DNA

Industry

Samenwerken is ons DNA

Industry

Health~Holland - Eureka Call Open

Industry

Health~Holland - Eureka Call Open

Industry

Health~Holland - Eureka Call Open

Industry

Xeltis joins High Tech Campus Eindhoven: A new home for regenerative MedTech

Industry

Xeltis joins High Tech Campus Eindhoven: A new home for regenerative MedTech

Industry

Xeltis joins High Tech Campus Eindhoven: A new home for regenerative MedTech

Industry

Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness

Industry

Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness

Industry

Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness

Load More Industry News

Featured

MORE

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Advertisement

Advertisement